Shagun Singh
Stock Analyst at RBC Capital
(2.38)
# 2,457
Out of 4,906 analysts
211
Total ratings
51.67%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Outperform | $181 → $185 | $164.36 | +12.56% | 22 | Jul 17, 2025 | |
| ZYXI Zynex | Maintains: Sector Perform | $4 → $3 | $2.34 | +28.21% | 8 | Jul 15, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $145 → $130 | $109.79 | +18.41% | 21 | Jul 15, 2025 | |
| ABT Abbott Laboratories | Maintains: Outperform | $145 → $147 | $124.42 | +18.15% | 14 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Outperform | $105 → $101 | $89.70 | +12.60% | 21 | May 22, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $14 → $21 | $17.51 | +19.93% | 11 | May 21, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $125 → $112 | $92.59 | +20.96% | 14 | May 6, 2025 | |
| PEN Penumbra | Maintains: Outperform | $315 → $330 | $228.86 | +44.19% | 14 | Apr 24, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $116 → $120 | $103.78 | +15.63% | 15 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $630 → $605 | $516.12 | +17.22% | 14 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $215 | $125.14 | +71.81% | 5 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $340 | $280.96 | +21.01% | 1 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $55 | $14.64 | +275.81% | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $76.56 | +11.02% | 21 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $387.32 | +12.31% | 19 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $92 | $51.89 | +77.30% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $115 | $84.03 | +36.86% | 4 | Oct 25, 2024 |
Johnson & Johnson
Jul 17, 2025
Maintains: Outperform
Price Target: $181 → $185
Current: $164.36
Upside: +12.56%
Zynex
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $2.34
Upside: +28.21%
Teleflex
Jul 15, 2025
Maintains: Sector Perform
Price Target: $145 → $130
Current: $109.79
Upside: +18.41%
Abbott Laboratories
Jul 15, 2025
Maintains: Outperform
Price Target: $145 → $147
Current: $124.42
Upside: +18.15%
Medtronic
May 22, 2025
Maintains: Outperform
Price Target: $105 → $101
Current: $89.70
Upside: +12.60%
Outset Medical
May 21, 2025
Maintains: Sector Perform
Price Target: $14 → $21
Current: $17.51
Upside: +19.93%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $125 → $112
Current: $92.59
Upside: +20.96%
Penumbra
Apr 24, 2025
Maintains: Outperform
Price Target: $315 → $330
Current: $228.86
Upside: +44.19%
Boston Scientific
Apr 24, 2025
Maintains: Outperform
Price Target: $116 → $120
Current: $103.78
Upside: +15.63%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $630 → $605
Current: $516.12
Upside: +17.22%
Apr 15, 2025
Maintains: Outperform
Price Target: $260 → $215
Current: $125.14
Upside: +71.81%
Mar 6, 2025
Initiates: Outperform
Price Target: $340
Current: $280.96
Upside: +21.01%
Feb 27, 2025
Maintains: Outperform
Price Target: $65 → $55
Current: $14.64
Upside: +275.81%
Feb 12, 2025
Reiterates: Outperform
Price Target: $85
Current: $76.56
Upside: +11.02%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $387.32
Upside: +12.31%
Nov 6, 2024
Maintains: Outperform
Price Target: $80 → $92
Current: $51.89
Upside: +77.30%
Oct 25, 2024
Maintains: Outperform
Price Target: $120 → $115
Current: $84.03
Upside: +36.86%